Syngene International per share figures

Share price at each year-end
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
₹4.63₹7.87₹12.35₹12.71₹11.59
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
₹4.62₹7.87₹12.34₹12.69₹11.51
₹120.11₹120.11₹117.44₹105.91₹90.13
₹87.42₹92.79₹90.49₹86.78₹79.54
—₹22.72₹29.01₹25.92₹20.52
₹13.58₹13.58₹9.88₹13.22₹7.60
—₹1.25₹1.25₹1.25₹1.00
40.340.340.340.240.1
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

SYNGENE₹398.60

Syngene International Ltd.

· Pharma & Health
₹ CrorePeersSAILIFEDIVISLABWOCKPHARMAGLANDASTERDMPPLPHARMACOHANCELALPATHLABMcap ₹16,060 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
₹ per share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Basic EPS11.5912.7112.357.874.63
Diluted EPS11.5112.6912.347.874.62
Book Value per Share90.13105.91117.44120.11120.11
Revenue per Share79.5486.7890.4992.7987.42
Cash Flow per Share20.5225.9229.0122.72—
Free Cash Flow per Share7.6013.229.8813.5813.58
Dividends per Share1.001.251.251.25—
Shares Outstanding (cr)40.140.240.340.340.3
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.